Status:

RECRUITING

Spinal Cord Stimulation (SCS) for Spinal Cord Injury (SCI)

Lead Sponsor:

Nandan Lad, M.D., Ph.D.

Conditions:

Spinal Cord Injury at T1-T12 Level

Traumatic Thoracic Spinal Cord Contusion

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this feasibility study is to compare the impact of Spinal cord stimulation \[SCS\] for Spinal Cord Injury (SCI) pain and rehabilitation. SCS, also known as Epidural Electrical Stimulati...

Detailed Description

This study is a prospective, single center study. Data will be collected at baseline, time of procedure (trial and permanent), trial phase, and at 1, 3, 6, 12, 18, and 24 months post-implantation. Th...

Eligibility Criteria

Inclusion

  • Subjects enrolled in this study must meet all of the following inclusion criteria (based on investigator judgement):
  • Traumatic, thoracic SCI
  • Chronic neuropathic pain (i.e., Pain \>3 for \> 3 months)
  • Willing and able to provide informed consent, attend required study visits, and complete required assessments/questionnaires
  • 18-80 years of age
  • Medically stable enough to undergo surgical implantation of an SCS / participate in rehabilitation regimens

Exclusion

  • Subjects enrolled in this study must not meet any of the following exclusion criteria (based on investigator judgement):
  • Complete cord transection
  • Persistent spinal instability or other injury preventing ability to participate
  • Active infection
  • Comorbid psychosis or psychotic disorder
  • Untreated, clinically significant depression
  • Active drug or alcohol abuse
  • Pregnant women or women who intend to become pregnant during the duration of the study. Women of childbearing potential need a negative pregnancy test
  • Patients without symptoms of neuropathic pain \>3/10 for \> 3 months
  • Patient deemed not medically stable for surgery

Key Trial Info

Start Date :

December 30 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2027

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04894734

Start Date

December 30 2021

End Date

October 31 2027

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Health Systems

Durham, North Carolina, United States, 27710